- The WisdomTree U.S. Quality Dividend Growth ETF ( DGRW ) focuses on the dividend growth & quality factors and could be uniquely positioned to outperform in a post-vaccine world Positioning For The Re-Opening Rally The news of Pfizer's potential coronavirus vaccine yielding very encouraging results in the early findings of its clinical trial was more than enough to send investors racing into risk assets betting that a full economic recovery could be on the way.
- Instead, DGRW looks at long-term earnings growth expectations as a proxy for a company's ability to continue paying and growing its dividend over time.
SaleBestseller No. 1
Retirement Planning Guidebook: Navigating the Important Decisions for Retirement Success (The Retirement Researcher Guide Series)
- Pfau, Wade (Author)
- English (Publication Language)
- 508 Pages - 03/15/2023 (Publication Date) -...
$29.66
Buy on Amazon
SaleBestseller No. 2
The 5 Years Before You Retire, Updated Edition: Retirement Planning When You Need It the Most
- Birken, Emily Guy (Author)
- English (Publication Language)
- 240 Pages - 05/11/2021 (Publication Date) - Adams...
$11.79
Buy on Amazon
Bestseller No. 3
Retirement Planning at 40 and Beyond: Simple guide to take control of your future, your finances, your investments and your time in retirement to the next level in 30 days
- Amazon Kindle Edition
- Holt, Richard (Author)
- English (Publication Language)
- 172 Pages - 07/19/2022 (Publication Date)
Last update on 2024-04-05 / Affiliate links / Images from Amazon Product Advertising API
Source: DGRW: Pfizer's Vaccine News Could Set This ETF Into Motion